(Q85428079)
Statements
Safety, tolerability, pharmacokinetics and pharmacodynamics of single doses of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in healthy Japanese subjects (English)
Akiko Sarashina
Kazuki Koiwai
Leo J Seman
Norio Yamamura
Atsushi Taniguchi
Takahiro Negishi
Shogo Sesoko
Hans J Woerle
13 November 2012